Literature DB >> 12234095

Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.

Mark E Lieb1, Keon Menzies, Maria C Moschella, Rujing Ni, Mark B Taubman.   

Abstract

The mammalian EGLN family contains three paralagous genes (EGLN1, EGLN2, and EGLN3) encoding prolyl hydroxylase isoforms that mediate the oxygen-dependent targeting of the transcription factor hypoxia inducible factor alpha to the proteosome. The rat orthologue of EGLN3 (SM-20) exhibits tissue-restricted expression, is induced by growth factors in cultured vascular smooth muscle, and is up-regulated during myogenesis. To determine if all three EGLN genes are coordinately regulated, we examined their mRNA expression in murine tissues and in cultured cells. We now report that the three murine EGLN mRNAs have unique but overlapping patterns of tissue expression. The most striking differences were in the heart, where EGLN3 had its highest levels of expression, and the testis, where EGLN2 was the only isoform expressed. In cultured vascular smooth muscle cells, serum treatment led to up-regulation of EGLN1 and EGLN3, but not EGLN2, and only EGLN3 was superinduced by cyclohexamide. In cultured C2C12 myocytes, EGLN3 was up-regulated during differentiation, whereas EGLN1 and EGLN2 were constitutively expressed. The abundance of EGLN3 mRNA in the heart, its induction by growth factors in vascular smooth muscle, and its regulation during C2C12 differentiation suggest a unique role for EGLN3 and might justify the development of isoformspecific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234095     DOI: 10.1139/o02-115

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  62 in total

1.  Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury.

Authors:  Marion Hölscher; Monique Silter; Sabine Krull; Melanie von Ahlen; Amke Hesse; Peter Schwartz; Ben Wielockx; Georg Breier; Dörthe M Katschinski; Anke Zieseniss
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

Review 2.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

Review 3.  The oxygen sensing signal cascade under the influence of reactive oxygen species.

Authors:  Helmut Acker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 4.  The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling.

Authors:  Edurne Berra; Amandine Ginouvès; Jacques Pouysségur
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

5.  Peroxisomal localization of hypoxia-inducible factors and hypoxia-inducible factor regulatory hydroxylases in primary rat hepatocytes exposed to hypoxia-reoxygenation.

Authors:  Zahida Khan; George K Michalopoulos; Donna Beer Stolz
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

Authors:  Luke Erber; Ang Luo; Yue Chen
Journal:  Mol Cell Proteomics       Date:  2019-06-25       Impact factor: 5.911

Review 7.  Cellular oxygen sensing in health and disease.

Authors:  David R Mole; Peter J Ratcliffe
Journal:  Pediatr Nephrol       Date:  2007-10-23       Impact factor: 3.714

8.  Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.

Authors:  Rhonda Souvenir; Jerry J Flores; Robert P Ostrowski; Anatol Manaenko; Kamil Duris; Jiping Tang
Journal:  Transl Stroke Res       Date:  2013-11-27       Impact factor: 6.829

9.  Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts.

Authors:  Ajith Vengellur; Barbara G Woods; Heather E Ryan; Randall S Johnson; John J LaPres
Journal:  Gene Expr       Date:  2003

10.  Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Authors:  Olga Aprelikova; Silvia Pandolfi; Sean Tackett; Mark Ferreira; Konstantin Salnikow; Yvona Ward; John I Risinger; J Carl Barrett; John Niederhuber
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.